What did Baxter International Inc. pay for RECOTHROM and PREVELEAK (Mallinckrodt)?

Baxter International Inc. acquired RECOTHROM and PREVELEAK (Mallinckrodt) for $153.0M in 2018, equivalent to 2.70x revenue. Target revenue was approximately $56.0M.

What does RECOTHROM and PREVELEAK (Mallinckrodt) do?

RECOTHROM and PREVELEAK (Mallinckrodt) is a medical devices business.

What multiple did Baxter International Inc. pay for RECOTHROM and PREVELEAK (Mallinckrodt)?

2.70x revenue, based on disclosed deal value of $153.0M and disclosed financials.

M&A TRANSACTION · 2018

RECOTHROM and PREVELEAK (Mallinckrodt) acquired by Baxter International Inc.

$153.0M· 2.70x revenue

Target

RECOTHROM and PREVELEAK (Mallinckrodt)

Acquirer

Baxter International Inc.

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$56.0M

EBITDA

—

Deal Value

$153.0M

EV/EBITDA

—

Context

This $153.0M acquisition of RECOTHROM and PREVELEAK (Mallinckrodt) by Baxter International Inc. sits in the medical devices sub-vertical. Baxter International Inc. is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from SEC filings and press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the RECOTHROM and PREVELEAK (Mallinckrodt) acquisition.

Citation: ExitValue.ai. (2018). RECOTHROM and PREVELEAK (Mallinckrodt) acquired by Baxter International Inc.. https://exitvalue.ai/deals/recothrom-and-preveleak-mallinckrodt-acquired-by-baxter-international-inc-hc-2018-0180